Back to results
US 9,290,820 B2Granted
Methods for detection of parvovirus B19
AssigneeGrifols Therapeutics Inc.
InventorsDouglas C. Lee, Todd M. Gierman, Chris Glenn, Burton Beams, Brett Buno, Lori Rinckel
Life of this patent
Estimating the term…
Abstract
Nucleic acid molecules derived from sequences of novel human parvovirus B19 variant genomes are provided. Also provided are assays and kits comprising the nucleic acid molecules.
Claims3
A method for detecting a parvovirus B19 nucleic acid in a sample, the method comprising:
- a) performing PCR with at least a portion of the sample using a forward primer, the nucleotide sequence of which consists of SEQ ID NO:145, and a reverse primer, the nucleotide sequence of which consists of SEQ ID NO:146;
- and
- b) determining the presence or absence of an amplicon, wherein the presence of the amplicon is indicative of the presence of the parvovirus B19 nucleic acid in the sample, wherein determining comprises annealing an oligonucleotide to the amplicon.
Dependencies are inferred from the claim text.